Tech Company Financing Transactions
General Proximity Funding Round
General Proximity, based in San Francisco, secured investment from Daewoong Pharmaceutical and FreeMind.
Transaction Overview
Company Name
Announced On
5/4/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
135 Mississippi Street
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We've assembled a world-class team of proximity scientists from Scripps, the Broad Institute, Harvard, MIT, Yale, Oxford, and UCSF, with industry experience across top pharma and biotech institutions such as Lilly, Novartis, AbbVie, Bristol Myers Squibb, Amgen, Genentech, Roche, Alnylam, and Arvinas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Armand Cognetta
Browse more venture capital transactions:
Prev: 5/4/2026: Barocal venture capital transaction
Next: 5/4/2026: mbiomics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs